Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bellmunt

Showing results (11-20 of 122) with videos related to

Pageof 13
Sort By:
Critical Reviews in Oncology/Hematology|July 22, 2008
Optimizing therapeutic strategies in advanced bladder cancer: update on chemotherapy and the role of targeted agentsJ Bellmunt, S Albiol, C Suárez, et al.
Journal of Surgical Oncology|August 1, 1996
Endobronchial metastatic disease: analysis of 32 casesA Salud, J M Porcel, A Rovirosa, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Ifosfamide + mitoxantrone in advanced breast cancer previously treated with anthracyclinesJ Bellmunt, S Morales, M Navarro, et al.
Tumori|June 30, 1988
Palmar-plantar erythrodysesthesia syndrome associated with short-term continuous infusion (5 days) of 5-fluorouracilJ Bellmunt, M Navarro, R Hidalgo, et al.
Medical Hypotheses|March 1, 1993
Mechanisms of glycation in atherogenesisR Pamplona, M J Bellmunt, M Portero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2014
New agents for prostate cancerN Agarwal, G Di Lorenzo, G Sonpavde, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2001
A feasibility study of carboplatin with fixed dose of gemcitabine in "unfit" patients with advanced bladder cancerJ Bellmunt, R de Wit, J Albanell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic featuresJ Bellmunt, C Szczylik, J Feingold, et al.
Gastroenterologia Y Hepatologia|April 6, 2006
[Peripheral cholangiocarcinoma: results of surgical treatment]C Margarit, A Escartín, J Bellmunt, et al.
International Urology and Nephrology|January 1, 1989
Orbital metastasis, by transitional cell carcinoma of the bladderJ Prats, J Bellmunt, M A Calvo, et al.
Pageof 13

Showing results (11-20 of 122) with videos related to

Sort By:
Pageof 13
Critical Reviews in Oncology/Hematology|July 22, 2008
Optimizing therapeutic strategies in advanced bladder cancer: update on chemotherapy and the role of targeted agentsJ Bellmunt, S Albiol, C Suárez, et al.
Journal of Surgical Oncology|August 1, 1996
Endobronchial metastatic disease: analysis of 32 casesA Salud, J M Porcel, A Rovirosa, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Ifosfamide + mitoxantrone in advanced breast cancer previously treated with anthracyclinesJ Bellmunt, S Morales, M Navarro, et al.
Tumori|June 30, 1988
Palmar-plantar erythrodysesthesia syndrome associated with short-term continuous infusion (5 days) of 5-fluorouracilJ Bellmunt, M Navarro, R Hidalgo, et al.
Medical Hypotheses|March 1, 1993
Mechanisms of glycation in atherogenesisR Pamplona, M J Bellmunt, M Portero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2014
New agents for prostate cancerN Agarwal, G Di Lorenzo, G Sonpavde, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 2001
A feasibility study of carboplatin with fixed dose of gemcitabine in "unfit" patients with advanced bladder cancerJ Bellmunt, R de Wit, J Albanell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 4, 2008
Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic featuresJ Bellmunt, C Szczylik, J Feingold, et al.
Gastroenterologia Y Hepatologia|April 6, 2006
[Peripheral cholangiocarcinoma: results of surgical treatment]C Margarit, A Escartín, J Bellmunt, et al.
International Urology and Nephrology|January 1, 1989
Orbital metastasis, by transitional cell carcinoma of the bladderJ Prats, J Bellmunt, M A Calvo, et al.
Pageof 13